The third joint BIA and MHRA conference (external link) will focus on supporting innovation in the development and regulation of biopharmaceuticals from both regulatory and life sciences industry perspectives.


This one day conference taking place on Wednesday 5 June in Central London is co-chaired by Dr Ian Hudson, Director of Licensing Division, MHRA and Vice-Chair of EMA’s Committee for Medicinal Products for Human Use (CHMP), and Alan Morrison, Vice President, International Regulatory Affairs and Safety, Amgen, and Chairman of BIA’s Regulatory Affairs Advisory Committee, is the ideal place to hear the very latest thinking from MHRA’s senior experts and industry-leading speakers in one central London location.


More details can be found on the BIA website